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Objective: The development of magnetic resonance (MR) imaging systems has been 40	  
extended for the entire radiotherapy process. However, MR images provide voxel values 41	  
that are not directly related to electron densities (ED), thus MR images cannot be used 42	  
directly for dose calculation. The aim of this study is to investigate the feasibility of dose 43	  
calculations to be performed on MR images and evaluate the necessity of re-planning. 44	  
Methods: A prostate cancer patient was imaged using both MR and CT. The multilevel 45	  
threshold algorithm (MLT) was used categorise to voxel values in the MR images in into 46	  
three segments (air, water and bone) with homogeneous Hounsfield units (HU). An 47	  
intensity modulated radiation therapy (IMRT) plan was generated from CT images of the 48	  
patient. The plan was then copied to the segmented MR data sets and the doses were 49	  
recalculated using pencil beam, and collapsed cone (CC) algorithms and Monte Carlo 50	  
(MC) modelling. 51	  
Results: Gamma evaluation showed that the percentage of points in regions of interest 52	  
with γ < 1 (3%/3 mm) were more than 94% in the segmented MR. Compared with the 53	  
planning CT (pCT) plan, the segmented MR plan resulted in a dose difference of –0.3%, 54	  
0.8% and –1.3% when using PB, CC and MC algorithms, respectively.  55	  
Conclusion: The segmentation and conversion of MR images into HUs data using the 56	  
MLT algorithm, used in this feasibility study, can be used for dose calculation. This 57	  
method can be used as a dosimetric assessment tool and can be easily implemented into 58	  
the clinic.  59	  
 60	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1 Introduction 62	  
In external beam radiotherapy of the prostate, magnetic resonance (MR) imaging is 63	  
considered to be the gold standard imaging modality for prostate delineation and disease 64	  
staging (1, 2). Compared with conventional CT, MR provides much better soft tissue 65	  
contrast of the prostate, the surrounding normal tissues and organs at risk. In CT, 66	  
identifying the prostate boundaries is challenging, whilst in MR images the boundaries of 67	  
the prostate as well as the peripheral zone and central gland can be identified (3). With 68	  
the development of more advanced radiotherapy treatment planning, such as intensity 69	  
modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT), the desire 70	  
for more accurate localization of tumours prior to and during the treatment delivery has 71	  
increased, ensuring that the higher tumour dose is achieved whilst reducing the dose to 72	  
organs at risk (OAR) and normal tissues. This can be achieved by the use of the cone-73	  
beam CT (CBCT) imaging system which is integrated in the linac, providing 3D 74	  
volumetric images before or during the treatment delivery (4).  75	  
   However, despite its major improvement in image guided radiotherapy (IGRT), the 76	  
image quality of CBCT images makes it hard to accurately identify the prostate, due to 77	  
the increased amount of scatter (5-7). More importantly, the CBCT imaging dose limits 78	  
the frequency with which this technique can be used (8). For these reasons, the MR 79	  
imaging system has been recently integrated in the linac system for offline/online 80	  
treatment guidance, such as the MRI-Linac, and in the Cobalt source unit as ViewRay, 81	  
and installed in the treatment room as the MR-on-rails (9-11). For a highly mobile and 82	  
challenging target, such as a prostate, MR imaging allows more accurate localization of 83	  
the prostate and intraprostatic lesions, as well as real-time imaging during beam delivery 84	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and thus provides information for adaptive radiotherapy (ART) (3). Therefore, MR 85	  
imaging can potentially manage inter- and intra-fraction motions. This would potentially 86	  
decrease the clinical target volume (CTV)-to-planning tumour volume (PTV) margin and 87	  
increase the confidence of boosting the target dose using fewer treatment fractions (12, 88	  
13).  89	  
   Despite its excellent soft tissue contrast, there are factors that can limit the 90	  
implementation of some MR imaging platforms into the radiotherapy process. These 91	  
factors include cost, system-related and patient-related geometric distortions (3, 14, 15). 92	  
One of the main factors that limits the use of MRI-only treatment planning, and the MRI-93	  
only simulator, is that MR images do not provide Hounsfield units (HU) and the 94	  
intensity, or voxel values are not directly related to electron densities (ED). Therefore, if 95	  
there are significant on-treatment patient shape changes observed on the MR images, as 96	  
an IGRT tool in a MRI-Linac, acquiring another CT is necessary for an accurate 97	  
assessment of dose differences. This procedure is time consuming across all staff groups 98	  
involved in the radiotherapy pathway and additional dose is delivered to the patients. 99	  
  There are different approaches to convert the voxel values of MR images into HUs to 100	  
produce pseudo-CT images, also known as substitute CT or synthetic CT (16-18). One of 101	  
these approaches uses a CT-based ED atlas with non-rigid registration to transfer CT ED 102	  
to MR images (19, 20). For prostate cancer patients using this approach, the dose 103	  
difference between the pseudo-CT and planning CT is within 2% (19). A limitation of 104	  
this approach is that it can be time consuming for multiple atlas and lead to greater 105	  
uncertainty if the patient is dissimilar to the database used for the atlas (20, 21). 106	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   Another approach for converting voxel values in MR images into HUs is by segmenting 107	  
MR images into a number of materials and subsequently applying bulk density 108	  
assignment. In this approach, the whole body can be considered as water-only, or water 109	  
and air materials (3). Lambert et al (2011) showed that the bone region should be 110	  
included for a more accurate dose calculation in the pelvic region (22). However, bone 111	  
regions and boundaries are hard to visualize in conventional or standard MR images (T1- 112	  
or T2-weighted), which is the standard sequence for diagnosis, due to the low proton 113	  
densities in these regions and short T2 (23, 24). Therefore, it is hard to differentiate 114	  
between air, lung and bone regions. To separate bone voxels, additional MR sequences 115	  
are used, such as ultra-short echo times (UTE) or T1/T2*-weighted (17, 25). However, 116	  
these MR sequences may increase signal-to-noise ratio at tissue interfaces, and 117	  
consequently lead to greater uncertainty in the conversion to HUs. In addition, these extra 118	  
MR sequences are time consuming and are not used in clinical radiotherapy (20, 21). The 119	  
bone regions can be manually or automatically contoured and then assigned with 120	  
different HUs, whilst soft tissues are converted to HUs using dual model conversion 121	  
techniques (24, 26). This approach, excluding the water-only method, resulted in a dose 122	  
accuracy of 1-3%. 123	  
   The aim of this study is to convert voxel values in MR images into HUs by segmenting 124	  
MR images into a number of materials using the multilevel threshold (MLT) algorithm. 125	  
The MLT algorithm has been used to enable dose calculation to be performed on CBCT 126	  
images by the authors previously, even for more challenging circumstances as for a 127	  
prostate patient with hip prostheses (6, 7). This method does not require database, as for 128	  
the atlas approach, nor extra non-clinical MR sequence. Furthermore, the effect of the 129	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segmentation process on the dose calculation algorithm accuracy is investigated using the 130	  
treatment planning system pencil beam (PB) and  collapsed cone (CC) algorithms and 131	  
Monte Carlo (MC) modelling. With the simplicity of this approach, it can be used as a 132	  
fast decision-making, dosimetric, tool regarding on-treatment patient shape changes and 133	  
whether a new CT is required. It is envisaged that the method can be applicable for the 134	  
automation of dose calculation on segmented MR images and could be of interest to MR-135	  
based ART (7, 27).	  136	  
2 Method and materials  137	  
2.1 Patient study 138	  
This study was performed on a patient with prostate cancer (High Risk) treated at the 139	  
Department of Clinical Oncology and Radiotherapy, South West Wales Cancer Centre 140	  
ABM University Health Board, Swansea, Wales. An IMRT treatment with five 6-MV 141	  
photon fields, at gantry angles of 180°, 100°, 35°, 260°, and 325° was performed. Dose 142	  
distribution was calculated using the Oncentra MasterPlan (OMP) treatment planning 143	  
system (version 4.3 Elekta, Best, Netherlands), PB and CC algorithms, to allow the 144	  
comparison with MC algorithm and to identify the effects of HU on dose calculation. 145	  
2.2 CT and MR image acquisition 146	  
The planning CT (pCT) images of a patient with prostate cancer was acquired using a 147	  
Philips Brilliance Big Bore CT scanner (version 2·3; Philips Medical Systems, Cleveland, 148	  
OH, USA). The pCT images were acquired with 120 kVp and the tube current was 149	  
modulated during the scan based on patient anatomy. The matrix size of the reconstructed 150	  
	  	   6	  
images was 512 × 512 and voxel sizes were 1.19 × 1.19 × 3 mm3. The acquisition of the 151	  
MR images of the patient was performed with the T2-weighted sequence using the 152	  
Toshiba scanner (1.5 Tesla, Toshiba Atlas, Tokyo, Japan), with a flat table as in the CT 153	  
simulator. This acquisition sequence is the standard sequence used in the local 154	  
department for prostate localization and delineation. The matrix size of the reconstructed 155	  
MR images was 512 × 512 and the voxel sizes were 0.74 × 0.74 × 5 mm3.  156	  
2.3 Modification of MR image 157	  
As mentioned before, acquiring MR images with the conventional or standard sequence 158	  
produces images with no contrast between bone and air (Figure 1b). In addition, the 159	  
femoral heads are mostly composed of bone marrow tissue, which has a wide intensity 160	  
range due to the proportions of adipose and water (24). Therefore, it is challenging to 161	  
accurately contour bone regions. However, MATLAB (version 2013a, Mathworks, 162	  
Natick, MA) scripts were developed so that contours could be drawn on the MR images. 163	  
There were 5 contours drawn (defined by the user and associated with its uncertainties in 164	  
defining bone region boundaries) on the MR image to enable accurate bone 165	  
representation, and to isolate bone tissue from the surrounding adipose and water tissues, 166	  
as shown in Figure 1b. This was done for each MR slice (total of 24 slices), and the 167	  
operator time was about 2 hours. In each region of interest (ROI), the MLT algorithm 168	  
(using a MATLAB script) was applied to convert voxel values into CT numbers that are 169	  
comparable with the pCT to generate segmented MR (sMR) images (Figure 1c). These 170	  
assigned CT numbers are based on the local fixed HU-ED calibration. Thus, for a wider 171	  
patient group, the same assigned CT numbers would be used for the same materials.	  172	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173	  
Furthermore, an additional contour was drawn as a body contour around the patient. To 174	  
reduce manual delineation or contouring time, regional coordinates were written in the 175	  
MLT algorithm that were expected to encompass the whole rectum, through all the slices 176	  
(Figure 1c). Any voxel inside this region only with a range voxel value between 0 and 177	  
110 was considered as air with –976 HU otherwise they were considered as water with 0 178	  
HU. Any voxel inside the bone contours, and outside the rectum region, with a range 179	  
value between 0 and 1150 was considered as bone with 528 HU otherwise they were 180	  
considered as water. Any voxel inside the body contour and outside both the bone 181	  
contours and the rectum region was considered as water. Moreover, as shown in Figure 1, 182	  
there is a missing volume laterally in the MR images, so the external contour of the MR 183	  
(a) (b) 
(c) 
Figure 1: A prostate patient scan using (a) pCT, (b) MR and (c) the resultant image after 
segmenting MR (sMR). 
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images was copied onto the pCT and any voxel outside this contour was considered as 184	  
air, thus matching the field of view (FOV) between the two scans. Even though the 185	  
cropped pCT and sMR images are not clinically acceptable, this is a feasibility study and 186	  
the general concept of segmenting MR images still holds. This method does not require 187	  
additional MR sequences that are not used in clinical radiotherapy, which is time 188	  
consuming. Finally, to enable dose calculation to be performed within sMR images using 189	  
OMP, the DICOM tags were modified to match pCT DICOM tags, otherwise OMP 190	  
calculates the dose with overriding the density. 191	  
2.4 Monte Carlo calculation  192	  
The Elekta Synergy linear accelerator was modeled using Electron Gamma Shower 193	  
(EGSnrc), which is one of the most popular MC codes for medical physics (28). 194	  
BEAMnrc and DOSXYZnrc are two applications in EGSnrc code that are used to 195	  
simulate the beam generated from the treatment head and to score dose deposition in 196	  
voxel grids, respectively. An automated procedure was developed and applied to the 197	  
DICOM-RT file to extract the treatment plan parameters, using a MATLAB script, and 198	  
then convert and write them in a MC-format input file (egsinp file) for BEAMnrc and 199	  
DOSXYZnrc, separately. In this study, 80 million particles were used for each beam to 200	  
provide an accurate simulation with a low (<2%) statistical uncertainty. High 201	  
performance computing (HPC-Wales) was used to speed up MC calculations (29). The 202	  
MC normalization was performed by calculating the dose in a water phantom under the 203	  
standard reference conditions (10 ×10 field size, 100 cm source-to-surface distance, 5 cm 204	  
depth). There is a 95% chance of the MC model being within the error bars. 205	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2.5 Treatment planning evaluation and comparison  206	  
The fusion of the sMR and pCT images was accomplished with manual rigid registration 207	  
using ProSoma software (v3.3, MedCom, Darmstadt, Germany). The pCT images were 208	  
resampled to the sMR images to enable direct comparison of dose calculations. The 209	  
resultant pCT data set contained 24 slices with a voxel size of 0.74 × 0.74 × 5 mm3. The 210	  
structure sets were then transferred to the sMR images without any modification except 211	  
the external contour. The plans were then copied to sMR using the same geometry and 212	  
monitor unit (MU) values and the doses were recalculated using PB, CC and MC 213	  
algorithms. The MC dose calculation was then performed on pCT and sMR images using 214	  
the same HU-ED calibration as in OMP. The MC dose file (.3ddose) and the DICOM-RT 215	  
file were then imported into the computational environment for radiotherapy research 216	  
(CERR) software to compare the resultant dose distribution. The clinical target volume 217	  
(CTV) comprises the prostate, and involved seminal vesicles, and was increased by a 1 218	  
cm anterior, left, right, superior and inferior margin and 0.5 cm posterior margin to give 219	  
the PTV. For the rectum, the circumference of the rectum was outlined in its entirety and 220	  
included the faecal contents. The entire bladder was outlined and the outside of the 221	  
bladder wall was included. The femoral heads, both left and right, were outlined to the 222	  
bottom of the curvature of their heads. The dose volume histograms (DVHs) were 223	  
generated for PTV, rectum, bladder and left and right femoral heads structures, and 224	  
compared between pCT and sMR plans. The coverage of the PTV, the dose to 95% of the 225	  
PTV (D95%) and the mean dose (Dmean) were compared. The relative volume doses to 226	  
the rectum and bladder (V60) and to the left and right femoral heads (V35) as well as the 227	  
mean dose (Dmean) were compared. The dose differences are quoted as percentages of 228	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local values. In addition, the Student t-test (using MATLAB) was performed in the mean 229	  
value of dose in the PTV, rectum, bladder and left and right femoral heads. To 230	  
quantitatively appraise the differences between pCT and sMR plans, especially for the 231	  
structures mentioned above, a gamma index analysis was performed using the pCT plan 232	  
as a reference. The criteria were set as 3 mm distance to agreement (DTA) and 3% dose 233	  
difference (DD) and 5% low dose threshold. Finally, dose at the isocentre (at the 234	  
geometric centre of the prostate PTV) was compared between the pCT and sMR plans. 235	  
3 Results and discussion  236	  
237	  
Figure 2 shows the DVH of the prostate IMRT plan with a prescription dose of 60 Gy in 238	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Figure 2: DVHs comparison between pCT (solid) and sMR (broken) plans for planning target 
volume, rectum, bladder and left and right femoral heads using collapsed cone algorithm 
(prescription dose 60 Gy). 
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20 fractions. It shows the dose of the pCT and sMR plans to the PTV, rectum, bladder, 239	  
right and left femoral head using the CC algorithm. 240	  
   It can be seen that the sMR plan is in a good agreement with the pCT plan. In general, 241	  
the sMR plan slightly underestimated the dose to all the structures when using all 242	  
algorithms. There are some differences and outlines but the general trend holds. The 243	  
largest differences were found in the rectal volume receiving 60 Gy where it was 244	  
underestimated by –56%, –17% and –66% when using PB, CC and MC algorithms, 245	  
respectively, as shown in Table 1. This may be due to the fact that the air/gas pocket 246	  
volume in the rectum in the sMR was less than in the pCT. This rectal volume difference 247	  
between sMR and pCT scans may be due to a real difference in the rectum volume 248	  
between the two scans. Another reason for the rectal volume difference may be due to the 249	  
threshold method, where the partial volume in the rectum was considered either air or 250	  
water based on the threshold values. For the left and right femoral heads, the largest 251	  
difference was found for the left femoral head volume receiving 35 Gy where it was 252	  
underestimated by –31% and –49% when using PB and CC algorithms, respectively. 253	  
However, these findings show that the MLT algorithm used in this study to segment MR 254	  
images resulted in a dose calculation that is comparable to the pCT.  255	  
Table 1 shows the Student t-test (last column) results against the hypothesis that the mean 256	  
value of dose in the PTV, rectum, bladder and left and right femoral heads for sMR plans 257	  
differ. For the PTV, the results show that there is no support for a difference in the mean 258	  
dose, but with poor confidence (p = 0.08). Only in the case of the bladder is support (p = 259	  
0.008) for a small difference in the mean. 260	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Table 1: Dose and coverage differences between pCT and sMR plans for the PTV, rectum, 261	  
bladder, left and right femoral head. The dose to 95% of PTV volume and mean dose and the 262	  
percentage of rectal and bladder volumes receiving 60 Gy and the percentage of left and right 263	  
femoral head volumes receiving 35 Gy. 264	  
  
pCT sMR 
PVAL 
PB CC MC PB CC MC 
PTV 
D95 61.1 59.8 58.7 60.3 59.4 59.2  - 
Dmean 62.5 61.5 60.9 62.1 61.1 60.8 0.08 
Rectum 
V60 12.3 2.3 4.5 5.3 1.9 1.5 - 
Dmean 39.1 37.1 33.3 37.8 37.2 36.1 0.64 
Bladder 
V60 10.8 9.9 9.8 10.1 8.8 8.6 - 
Dmean 29.8 29.5 28.8 29.4 29.1 28.3 0.008 
Left femoral head 
V35 6.6 5.1 3.5 4.5 2.6 3.4 - 
Dmean 19.8 19.4 18.5 19.5 19.2 18.7 0.57 
Right femoral head 
V35 9.3 6.9 5.1 7.4 5.5 6.1 - 
Dmean 16.5 16.2 15.5 16.3 16.1 15.7 0.91 
Dmean , mean dose; D95, dose to 95% of the PTV; CC, collapsed cone; MC, Monte Carlo 265	  
algorithm; PB, pencil beam; pCT, planning CT; PTV, planning target volume; PVAL, p-value; 266	  
sMR, segmented magnetic resonance; V35 and V60, volumes receiving 35 Gy and 60 Gy. 267	  
Table 2 shows the γ index evaluation for the calculation points falling inside the PTV, 268	  
rectum, bladder and right and left femoral heads for the sMR plan using PB, CC and MC 269	  
algorithms. The results are shown as the percentage of calculation points resulting in γ ≤ 270	  
1. As mentioned before, there was a difference in the rectal volume between the pCT and 271	  
sMR. This difference resulted in 84%, 82% and 81% of the calculation points passed the 272	  
test, for the rectum region, when using PB, CC and MC algorithms, respectively. For the 273	  
left and right femoral head regions, almost all calculation points passed the 3%/3mm 274	  
criteria when using PB, CC and MC algorithms. This shows that the MLT algorithm 275	  
	  	   13	  
correctly replaced the voxel values with bone HU value, with an acceptable level of 276	  
accuracy. 277	  
Table 2: Summary of the gamma (γ) index with fixed distance to agreement = 3 mm and dose 278	  
difference = 3% for the calculation points falling inside the PTV, rectum, bladder, right and left 279	  
femoral head. It shows the percentage of points resulting with γ ≤ 1. 280	  
 sMR 
  PB                CC MC 
PTV 94.90 97.83 99.66 
Rectum 84.05 81.92 81.44 
Bladder 100 100 100 
Left femoral head 100 100 99.87 
Right femoral head 100 100 99.94 
CC, collapsed cone; MC, Monte Carlo algorithm; PB, pencil beam; PTV, planning target volume; 281	  
sMR, segmented magnetic resonance. 282	  
Table 3 shows the dose, in Gy, of the pCT and sMR plans at the isocentre (the geometric 283	  
centre of the prostate PTV) using PB, CC and MC algorithms. The segmentation of MR 284	  
images using the MLT algorithm used in this study resulted in a dose difference of –285	  
0.3%, 0.8% and –1.3% when using PB, CC and MC algorithms, respectively. This is 286	  
expected as that the PB algorithm in OMP calculates dose to water, whereas the CC 287	  
algorithm calculates dose to medium as does the MC algorithm (30). Therefore, the PB 288	  
algorithm would be less sensitive than CC and MC algorithms. However, this showed 289	  
that sMR plan resulted in differences of less than –2% compared with the pCT plan when 290	  
using all algorithms, which is considered to be clinically acceptable. As a result, this 291	  
segmentation technique is applicable for MR images and can be used as a quick-decision 292	  
making tool for re-planning regarding on-treatment patient shape changes and whether a 293	  
new CT is required. The operator time associated with this technique would be greatly 294	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reduced (approximately to 10-15 mins) with automation, which is currently being 295	  
investigated. Reduction of approximately 95% was achieved with an automated MLT 296	  
algorithm that developed for segmenting CBCT images (7). However, compared with the 297	  
proposed technique in this paper, acquiring a new CT is more time consuming, increase 298	  
work load on physicists, physicians, and radiographers, which can take up to a day in a 299	  
busy radiotherapy department, and more importantly additional dose is delivered to the 300	  
patient. 301	  
Table 3: Dose comparison between pCT and sMR plans at the isocentre using PB, CC and MC 302	  
algorithms. 303	  
Scan 
pCT sMR 
PB CC MC PB CC MC 
Dose at 
 isocentre (Gy) 61.9 60.6 61.3 61.7 61.1 60.5 
CC, collapsed cone; MC, Monte Carlo algorithm; PB, pencil beam; pCT, planning CT; sMR, 304	  
segmented magnetic resonance. 305	  
4 Conclusion  306	  
The segmentation and conversion of MR images into HUs/EDs data using the MLT 307	  
algorithm used in this study can be used for dose calculation. The MR images were 308	  
segmented into three materials mainly air, water and bone. The bone regions were 309	  
contoured to isolate bone tissue from the surrounding tissues before the segmentation 310	  
process. The segmented MR images provide accurate dose calculations with differences 311	  
of less than 2%. The simplicity of this method makes it easier to be implemented into the 312	  
clinic. Therefore, this method can be as a dosimetric assessment tool and can be of 313	  
interest to MRI-only based radiotherapy treatment planning and MR-based ART.  314	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